Cinven emerges as winning suitor for PE-backed BioClinica
Water Street Healthcare Partners and JLL Partners have concluded a Jefferies LLC-run sales process for BioClinica Inc., selling the technology-driven provider of clinical trial services to European sponsor Cinven Ltd. for an enterprise value of $1.4 billion, The Deal has learned.
Financial terms of the secondary buyout, announced late Monday, were not disclosed. The deal is expected to close in this year's fourth quarter.
The announcement follows what was said to be a competitive pro...